Skip to main content
16 Nov | 2022

The validity of nine biomarkers for diagnosing Alzheimer's disease in daily clinical practice has been determined

A study led by the Hospital del Mar Medical Research Institute, the Barcelonaβeta Brain Research Centre and the University of Gothenburg has compared the validity of nine biomarkers for the day-to-day diagnosis of Alzheimer's disease in hospital centres.

03 Nov | 2022

New data indicate an association between poor sleep quality and an increased risk of developing Alzheimer's

The research, within the European project EPAD, is headed by the Barcelonaβeta Brain Research Center (BBRC), a research center of the Pasqual Maragall Foundation, together with the University of Bristol.

28 Oct | 2022

Raffaele Cacciaglia receives the Ramón y Cajal 2021 grant

The award is a recognition of the trajectory of the researcher, recipient in addition to a Knowledge Generation Project 2021

18 Oct | 2022

Relationship between symptoms of anxiety and depression during confinement and subjective cognitive decline found

In the research, led by the BBRC, 250 people without cognitive alterations from the ALFA Study, promoted by the ”la Caixa” Foundation, have participated.

10 Oct | 2022

The AMYPAD project is successfully completed

The consortium has officially ended its formal operation after six years of joint efforts and collaboration.

29 Sep | 2022

Positive results of a new drug against Alzheimer's

As indicated by Biogen y Eisai, the results show a 27% slowing of cognitive impairment in patients in the early stages of Alzheimer's disease.

28 Sep | 2022

Demonstrated a greater consumption of cerebral glucose in the early stages of Alzheimer's associated with the activation of astrocytes

In the research, led by the Barcelonaβeta Brain Research Center (BBRC), a research center of the Pasqual Maragall Foundation, 314 people without cognitive alterations from the Alfa Study, which has the support of the ”la Caixa” Foundation, have participated - DESTACAT

21 Sep | 2022

Research support, key to Alzheimer's prevention

Thanks to the Alfa study, which has the support of the ”la Caixa” Foundation, much progress has been made in recent years in the identification of the early pathophysiological characteristics of Alzheimer's disease, as well as in the its early detection and in the development of prevention strategies.

21 Sep | 2022

Let's make September 21, World Alzheimer's Day, #adaytoforget

On World Alzheimer's Day, we want to make visible the need to continue allocating resources to erase this date from the calendar.